A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of different doses of
JNJ-42160443 with placebo in the treatment of chronic, moderate to severe low back pain
patients with a diagnosis of chronic low back pain.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.